Jesy Nelson has praised plans to add Spinal Muscular Atrophy screening to England's newborn heel prick test as a "victory" for families affected by the rare genetic disorder. The pop star, who has been vocal about health advocacy, celebrated the expansion of routine screening that will now detect SMA in newborns across England.
SMA is a life-limiting condition that affects muscle strength and function. Early detection through newborn screening enables faster intervention and treatment, which can significantly improve outcomes for infants diagnosed with the disorder. The heel prick test, already standard for newborns in England, identifies several inherited conditions within days of birth.
Adding SMA to the screening panel represents a major shift in neonatal care. The condition, caused by mutations in the SMN1 gene, can progress rapidly in infants. Access to early treatment options like gene therapies and other interventions has transformed prognosis dramatically over recent years, making timely diagnosis critical.
The expansion follows advocacy efforts from patient groups and public figures like Nelson, who has leveraged her platform to push for increased awareness and resources around rare diseases. The announcement reflects growing recognition that genetic screening at birth can catch conditions early enough to make meaningful therapeutic interventions possible.
Health officials expect the new screening protocol to identify affected infants sooner, connecting families to specialist care and treatment options without delay. The move positions England alongside other healthcare systems expanding newborn screening panels to capture rare but treatable conditions.